Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-07-12
1997-09-02
Davenport, Avis M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 18, 514 16, 530328, 530329, 530330, 530331, A61K 3800, C07K 500, C07K 700, C07K 1700
Patent
active
056631480
ABSTRACT:
Oligopeptide compounds or oligopeptide analague compounds of the formula, A-B-D-E-G-J-L-M-N(R.sup.4)Arg-OH, which are ligands for the anaphylatoxin receptor and are useful in the treatment of inflammatory disease states, as well as anaphylatoxin receptor ligand compositions and a method for modulating anaphylatoxin activity.
REFERENCES:
patent: 5223485 (1993-06-01), Kawai et al.
Gerard et al., Journal of Immunology, vol. 127, No. 5, Nov. 1981, pp. 1978-1982.
Ember et al., Journal of Immunology, vol. 148, No. 10, May 15, 1992, pp. 3165-3173.
Luly Jay R.
Or Yat Sun
Abbott Laboratories
Davenport Avis M.
Janssen Jerry F.
LandOfFree
Anaphylatoxin receptor ligands containing lipophilic residues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anaphylatoxin receptor ligands containing lipophilic residues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anaphylatoxin receptor ligands containing lipophilic residues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-308108